Home › Myasthenia Gravis › South Carolina
Myasthenia Gravis clinical trials in South Carolina
7 studies for Myasthenia Gravis are looking for participants at sites in South Carolina.
Cities in South Carolina
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
- TG Therapeutics Investigational Trial Site, Greenville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07673744Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Clinical Trials of South Carolina - Charleston, Charleston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06463587A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
- Clinical Trials of South Carolina - Neurology, Charleston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07501702Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1030, Charleston
- Site Number - 1015, Charleston
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Jul 30, 2026 · NCT07039916A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Medical University of South Carolina, Charleston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT04951622A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Medical University of South Carolina, Charleston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06298565Vitaccess Real MG Registry
- Medical University South Carolina, Charleston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 29, 2025 · NCT06064461From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.